FREE UK SHIPPING ORDER BY 12:00 · SAME-DAY DISPATCH 20% FIRST REGISTERED ORDER 10% RETURNING CUSTOMER PRICING LIVE STOCK & PRICING SECURE STRIPE CHECKOUT RESEARCH USE ONLY DIRECT UK SUPPORT FREE UK SHIPPING ORDER BY 12:00 · SAME-DAY DISPATCH 20% FIRST REGISTERED ORDER 10% RETURNING CUSTOMER PRICING LIVE STOCK & PRICING SECURE STRIPE CHECKOUT RESEARCH USE ONLY DIRECT UK SUPPORT
SLSYNTRALABS
SYNTRA LABSFree UK shipping · 12:00 dispatch cutoff
FREE UK SHIPPINGAfter 12:00 · next working-day dispatchCutoff 12:00 UK
CELLULARSL-CERE60
CURRENT OFFER30% OFF
Cerebrolysin 60 mg
CATALOGUE IMAGEResearch-use presentation
Home/Catalogue/CERE60
Cellular · CERE60

Cerebrolysin

60 mg

Peptide / amino-acid preparation. Presented as a catalogue material for controlled laboratory research workflows.

0160 mg format02Cellular research03Live UK stock
CURRENT OFFER
£43.40£62.00
Save £18.60 · 30%
Live · 10 in stockAvailable from current UK catalogue stock
Server-verified priceSecure Stripe checkoutLive catalogue stockUK support
EVIDENCE ORIENTATIONClinical literature

This material is better described by its study history and proposed neurotrophic research context than by broad efficacy statements.

RESEARCH DOSSIER · SL-CERE60

Cerebrolysin: compound context & catalogue record.

Compound-level literature, catalogue specifications and availability are deliberately separated so scientific context is not confused with product validation.

Clinical literature
CATALOGUE IDSL-CERE60Cellular
PRESENTATION60 mgResearch vial
FOCUS AREAS3Mapped themes
REFERENCES2Selected literature
COMPOUND CLASS

Peptide / amino-acid preparation

A complex preparation of low-molecular-weight peptides and amino acids investigated in neurotrophic and neuroprotection research.

EVIDENCE SUMMARY

Clinical literature

Cerebrolysin has been investigated in animal models and randomized human studies across several neurological settings. The evidence base is heterogeneous, so a professional research page should present the literature without implying a universal clinical conclusion.

INTERPRETATION

This material is better described by its study history and proposed neurotrophic research context than by broad efficacy statements.

Research-use information only.No section of this dossier provides medical advice, dosing, administration instructions or veterinary guidance; selected references describe the named compound or pathway and do not independently validate this catalogue item.
RELATED CATALOGUE MATERIALS

Continue within this research category.

Full catalogue →
60 mg£43.40
Cerebrolysin 60 mg | Syntra Labs